Nkarta Inc. (NASDAQ: NKTX) announced on Tuesday the underwriters for its initial public offering have completely exercised their overal read more
Biopharmaceutical Company Nkarta Raises $290M In IPO
Leave a reply
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Foreaders 